SuperworthCabot EPS CBT
Diluted earnings per share by quarter and over the last twelve months, from 2009.
- Last 12 months, to Jun 30, 2026
- $3.54
- Latest quarter, Q3 FY26
- $0.12
- −94% on a year earlier
- Fiscal year 2025
- $6.00
- −11% on the year before
Cabot's earnings per share was $3.54 over the twelve months to Jun 30, 2026, down 54% on a year earlier.
In its latest quarter, Q3 FY26, it was $0.12, down 94% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $6.00 | −11% |
| FY2024 | $6.73 | −13% |
| FY2023 | $7.76 | +116% |
| FY2022 | $3.59 | −17% |
| FY2021 | $4.35 | n/a |
| FY2020 | −$4.24 | −261% |
| FY2019 | $2.63 | n/a |
| FY2018 | −$1.87 | −148% |
| FY2017 | $3.92 | +66% |
| FY2016 | $2.36 | n/a |
| FY2015 | −$5.31 | −275% |
| FY2014 | $3.03 | +28% |
| FY2013 | $2.36 | −61% |
| FY2012 | $5.99 | +68% |
| FY2011 | $3.57 | +52% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q3 FY26 | $0.12 | −94% | $3.54 | |
| Q2 FY26 | $1.27 | −25% | $5.28 | |
| Q1 FY26 | $1.37 | −18% | $5.70 | |
| Q4 FY25 | $0.78 | −68% | $6.00 | |
| Q3 FY25 | $1.86 | −4% | $7.64 | |
| Q2 FY25 | $1.69 | +13% | $7.72 | |
| Q1 FY25 | $1.67 | +90% | $7.52 | |
| Q4 FY24 | $2.42 | −41% | $6.73 | |
| Q3 FY24 | $1.94 | +36% | $8.42 | |
| Q2 FY24 | $1.49 | +16% | $7.91 | |
| Q1 FY24 | $0.88 | −5% | $7.71 | |
| Q4 FY23 | $4.11 | +152% | $7.76 |
Against its peers
Companies in Chemicals nearest Cabot's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| CBTCabot | $3.54 | −54% a year |
| AVNTAvient | $1.85 | +43% a year |
| CSWCSW Industrials | $7.29 | −13% a year |
| WDFCWD 40 | $6.58 | +4% a year |
| FULFuller H B | $3.59 | +72% a year |
| BCPCBalchem | $5.09 | +16% a year |
| IOSPInnospec | $4.90 | +545% a year |
| HXLHexcel | $1.99 | +84% a year |
| NGVTIngevity | $1.47 | |
| ROGRogers | $1.75 | |
| EMNEastman Chemical | $3.84 | −46% a year |
| Peer median | $3.71 |
Where Cabot ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Cabot
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.